DJIA 17,150.27 119.13 0.70%
NASDAQ 4,550.95 32.05 0.71%
S&P 500 2,001.37 17.24 0.87%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade

3 Drugs Stocks On The Rise

Top 3 Yielding Buy-Rated Stocks: PAA, VZ, GSK

Closing Update: Dow, S&P 500 Finish With New Records, Supported by Cyclical Stocks, Positive Data

GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients Wit

GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia

Sector Update: Health Care Stocks Climbing in Late Trade; Merck Hits 11-Year High After Teaming Up W

Sector Update: Health Care Stocks Climbing in Late Trade; Merck Hits 11-Year High After Teaming Up With Pfizer on Cancer Treatment

4 Foreign Blue-Chip Stocks With 4% Dividend Yields to Buy

Should Gilead Sciences, inc. Fear This New Competitor Drug?

GlaxoSmithKline and Pfizer's ViiV have won approval for a new HIV therapy that may work better than Gilead's Atripla.

ViiV Healthcare's Single-Pill HIV Drug Triumeq Cleared by FDA - Analyst Blog

Big deals push biotech stocks higher

See More Articles...